VIKING THERAPEUTICS INC (VKTX)

US92686J1060 - Common Stock

42.53  -0.36 (-0.84%)

After market: 42.7 +0.17 (+0.4%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
133.97M100.83M70.36M55.68M42.66M
Research and Development
91.16M63.81M54.23M44.98M31.93M
Selling, General, and Administrative Expenses
42.81M37.02M16.12M10.70M10.73M
Operating Income
-133.97M-100.83M-70.36M-55.68M-42.66M
Interest Income/Expense
34.82M14.93M1.49M690.00K3.17M
Other Income/Expense
N/AN/AN/AN/AN/A
Income Before Taxes
-99.15M-85.89M-68.87M-54.99M-39.50M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-99.15M-85.89M-68.87M-54.99M-39.50M
 
Per Share Data
EPS Diluted Total Ops
-0.94-0.91-0.90-0.71-0.54
Non GAAP EPS
-0.93-0.92-0.91-0.72-0.54
 
Statistics

All data in USD

Charts